 | • レポートコード：D005-00727 • 出版社/出版日：GlobalInfoResearch / 2020年5月29日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、ナノ粒子の世界市場を広く調査・分析し、今後の市場展望をまとめております。ナノ粒子の種類別市場規模（リポソーム、高分子複合薬剤、高分子ナノ粒子、デンドリマー、無機ナノ粒子、その他）、用途別市場規模（病院、外来手術センター、診断センター）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Novartis、Amgen、Gilead Sciences、Nano Interface Technology、Johnson & Johnson、Abraxis Biosciences、Sigma-Tau Pharmaceuticals ・地域別グローバル市場分析 2015年-2020年 ・ナノ粒子の北米市場（アメリカ、カナダ、メキシコ） ・ナノ粒子のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・ナノ粒子のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・ナノ粒子の南米市場（ブラジル、アルゼンチン） ・ナノ粒子の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：リポソーム、高分子複合薬剤、高分子ナノ粒子、デンドリマー、無機ナノ粒子、その他 ・用途別分析：病院、外来手術センター、診断センター ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Nanoparticles market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Nanoparticles market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Nanoparticles market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Nanoparticles market has been segmented into:
Liposomes
Polymer-Conjugated Drugs
Polymeric Nanoparticles
Dendrimers
Inorganic Nanoparticles
Others
By Application, Nanoparticles has been segmented into:
Hospitals
Ambulatory Surgery Centers
Diagnostic Centers
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Nanoparticles market presented in the report. This section sheds light on the sales growth of different regional and country-level Nanoparticles markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Nanoparticles market.
The report offers in-depth assessment of the growth and other aspects of the Nanoparticles market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Nanoparticles Market Share Analysis
Nanoparticles competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Nanoparticles sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Nanoparticles sales, revenue and market share for each player covered in this report.
The major players covered in Nanoparticles are:
Novartis
Amgen
Gilead Sciences
Nano Interface Technology
Johnson & Johnson
Abraxis Biosciences
Sigma-Tau Pharmaceuticals
Table of Contents
1 Nanoparticles Market Overview
1.1 Product Overview and Scope of Nanoparticles
1.2 Classification of Nanoparticles by Type
1.2.1 Global Nanoparticles Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Nanoparticles Revenue Market Share by Type in 2019
1.2.3 Liposomes
1.2.4 Polymer-Conjugated Drugs
1.2.5 Polymeric Nanoparticles
1.2.6 Dendrimers
1.2.7 Inorganic Nanoparticles
1.2.8 Others
1.3 Global Nanoparticles Market by Application
1.3.1 Overview: Global Nanoparticles Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Ambulatory Surgery Centers
1.3.4 Diagnostic Centers
1.4 Global Nanoparticles Market by Regions
1.4.1 Global Nanoparticles Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Nanoparticles (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Nanoparticles Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Nanoparticles Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Nanoparticles Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Nanoparticles Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Nanoparticles Status and Prospect (2015-2025)
2 Company Profiles
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Novartis SWOT Analysis
2.1.4 Novartis Product and Services
2.1.5 Novartis Nanoparticles Revenue, Gross Margin and Market Share (2018-2019)
2.2 Amgen
2.2.1 Amgen Details
2.2.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Amgen SWOT Analysis
2.2.4 Amgen Product and Services
2.2.5 Amgen Nanoparticles Revenue, Gross Margin and Market Share (2018-2019)
2.3 Gilead Sciences
2.3.1 Gilead Sciences Details
2.3.2 Gilead Sciences Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Gilead Sciences SWOT Analysis
2.3.4 Gilead Sciences Product and Services
2.3.5 Gilead Sciences Nanoparticles Revenue, Gross Margin and Market Share (2018-2019)
2.4 Nano Interface Technology
2.4.1 Nano Interface Technology Details
2.4.2 Nano Interface Technology Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Nano Interface Technology SWOT Analysis
2.4.4 Nano Interface Technology Product and Services
2.4.5 Nano Interface Technology Nanoparticles Revenue, Gross Margin and Market Share (2018-2019)
2.5 Johnson & Johnson
2.5.1 Johnson & Johnson Details
2.5.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Johnson & Johnson SWOT Analysis
2.5.4 Johnson & Johnson Product and Services
2.5.5 Johnson & Johnson Nanoparticles Revenue, Gross Margin and Market Share (2018-2019)
2.6 Abraxis Biosciences
2.6.1 Abraxis Biosciences Details
2.6.2 Abraxis Biosciences Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Abraxis Biosciences SWOT Analysis
2.6.4 Abraxis Biosciences Product and Services
2.6.5 Abraxis Biosciences Nanoparticles Revenue, Gross Margin and Market Share (2018-2019)
2.7 Sigma-Tau Pharmaceuticals
2.7.1 Sigma-Tau Pharmaceuticals Details
2.7.2 Sigma-Tau Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Sigma-Tau Pharmaceuticals SWOT Analysis
2.7.4 Sigma-Tau Pharmaceuticals Product and Services
2.7.5 Sigma-Tau Pharmaceuticals Nanoparticles Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Nanoparticles Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Nanoparticles Players Market Share
3.2.2 Top 10 Nanoparticles Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Nanoparticles Revenue and Market Share by Regions
4.2 North America Nanoparticles Revenue and Growth Rate (2015-2020)
4.3 Europe Nanoparticles Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Nanoparticles Revenue and Growth Rate (2015-2020)
4.5 South America Nanoparticles Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Nanoparticles Revenue and Growth Rate (2015-2020)
5 North America Nanoparticles Revenue by Countries
5.1 North America Nanoparticles Revenue by Countries (2015-2020)
5.2 USA Nanoparticles Revenue and Growth Rate (2015-2020)
5.3 Canada Nanoparticles Revenue and Growth Rate (2015-2020)
5.4 Mexico Nanoparticles Revenue and Growth Rate (2015-2020)
6 Europe Nanoparticles Revenue by Countries
6.1 Europe Nanoparticles Revenue by Countries (2015-2020)
6.2 Germany Nanoparticles Revenue and Growth Rate (2015-2020)
6.3 UK Nanoparticles Revenue and Growth Rate (2015-2020)
6.4 France Nanoparticles Revenue and Growth Rate (2015-2020)
6.5 Russia Nanoparticles Revenue and Growth Rate (2015-2020)
6.6 Italy Nanoparticles Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Nanoparticles Revenue by Countries
7.1 Asia-Pacific Nanoparticles Revenue by Countries (2015-2020)
7.2 China Nanoparticles Revenue and Growth Rate (2015-2020)
7.3 Japan Nanoparticles Revenue and Growth Rate (2015-2020)
7.4 Korea Nanoparticles Revenue and Growth Rate (2015-2020)
7.5 India Nanoparticles Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Nanoparticles Revenue and Growth Rate (2015-2020)
8 South America Nanoparticles Revenue by Countries
8.1 South America Nanoparticles Revenue by Countries (2015-2020)
8.2 Brazil Nanoparticles Revenue and Growth Rate (2015-2020)
8.3 Argentina Nanoparticles Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Nanoparticles by Countries
9.1 Middle East & Africa Nanoparticles Revenue by Countries (2015-2020)
9.2 Saudi Arabia Nanoparticles Revenue and Growth Rate (2015-2020)
9.3 UAE Nanoparticles Revenue and Growth Rate (2015-2020)
9.4 Egypt Nanoparticles Revenue and Growth Rate (2015-2020)
9.5 South Africa Nanoparticles Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Nanoparticles Revenue and Market Share by Type (2015-2020)
10.2 Global Nanoparticles Market Forecast by Type (2019-2024)
10.3 Liposomes Revenue Growth Rate (2015-2025)
10.4 Polymer-Conjugated Drugs Revenue Growth Rate (2015-2025)
10.5 Polymeric Nanoparticles Revenue Growth Rate (2015-2025)
10.6 Dendrimers Revenue Growth Rate (2015-2025)
10.7 Inorganic Nanoparticles Revenue Growth Rate (2015-2025)
10.8 Others Revenue Growth Rate (2015-2025)
11 Global Nanoparticles Market Segment by Application
11.1 Global Nanoparticles Revenue Market Share by Application (2015-2020)
11.2 Nanoparticles Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Ambulatory Surgery Centers Revenue Growth (2015-2020)
11.5 Diagnostic Centers Revenue Growth (2015-2020)
12 Global Nanoparticles Market Size Forecast (2021-2025)
12.1 Global Nanoparticles Market Size Forecast (2021-2025)
12.2 Global Nanoparticles Market Forecast by Regions (2021-2025)
12.3 North America Nanoparticles Revenue Market Forecast (2021-2025)
12.4 Europe Nanoparticles Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Nanoparticles Revenue Market Forecast (2021-2025)
12.6 South America Nanoparticles Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Nanoparticles Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Nanoparticles Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Nanoparticles by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Nanoparticles Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Nanoparticles Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Novartis Corporate Information, Location and Competitors
Table 6. Novartis Nanoparticles Major Business
Table 7. Novartis Nanoparticles Total Revenue (USD Million) (2017-2018)
Table 8. Novartis SWOT Analysis
Table 9. Novartis Nanoparticles Product and Solutions
Table 10. Novartis Nanoparticles Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Amgen Corporate Information, Location and Competitors
Table 12. Amgen Nanoparticles Major Business
Table 13. Amgen Nanoparticles Total Revenue (USD Million) (2018-2019)
Table 14. Amgen SWOT Analysis
Table 15. Amgen Nanoparticles Product and Solutions
Table 16. Amgen Nanoparticles Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Gilead Sciences Corporate Information, Location and Competitors
Table 18. Gilead Sciences Nanoparticles Major Business
Table 19. Gilead Sciences Nanoparticles Total Revenue (USD Million) (2017-2018)
Table 20. Gilead Sciences SWOT Analysis
Table 21. Gilead Sciences Nanoparticles Product and Solutions
Table 22. Gilead Sciences Nanoparticles Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Nano Interface Technology Corporate Information, Location and Competitors
Table 24. Nano Interface Technology Nanoparticles Major Business
Table 25. Nano Interface Technology Nanoparticles Total Revenue (USD Million) (2017-2018)
Table 26. Nano Interface Technology SWOT Analysis
Table 27. Nano Interface Technology Nanoparticles Product and Solutions
Table 28. Nano Interface Technology Nanoparticles Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Johnson & Johnson Corporate Information, Location and Competitors
Table 30. Johnson & Johnson Nanoparticles Major Business
Table 31. Johnson & Johnson Nanoparticles Total Revenue (USD Million) (2017-2018)
Table 32. Johnson & Johnson SWOT Analysis
Table 33. Johnson & Johnson Nanoparticles Product and Solutions
Table 34. Johnson & Johnson Nanoparticles Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Abraxis Biosciences Corporate Information, Location and Competitors
Table 36. Abraxis Biosciences Nanoparticles Major Business
Table 37. Abraxis Biosciences Nanoparticles Total Revenue (USD Million) (2017-2018)
Table 38. Abraxis Biosciences SWOT Analysis
Table 39. Abraxis Biosciences Nanoparticles Product and Solutions
Table 40. Abraxis Biosciences Nanoparticles Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Sigma-Tau Pharmaceuticals Corporate Information, Location and Competitors
Table 42. Sigma-Tau Pharmaceuticals Nanoparticles Major Business
Table 43. Sigma-Tau Pharmaceuticals Nanoparticles Total Revenue (USD Million) (2017-2018)
Table 44. Sigma-Tau Pharmaceuticals SWOT Analysis
Table 45. Sigma-Tau Pharmaceuticals Nanoparticles Product and Solutions
Table 46. Sigma-Tau Pharmaceuticals Nanoparticles Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Global Nanoparticles Revenue (Million USD) by Players (2015-2020)
Table 48. Global Nanoparticles Revenue Share by Players (2015-2020)
Table 49. Global Nanoparticles Revenue (Million USD) by Regions (2015-2020)
Table 50. Global Nanoparticles Revenue Market Share by Regions (2015-2020)
Table 51. North America Nanoparticles Revenue by Countries (2015-2020)
Table 52. North America Nanoparticles Revenue Market Share by Countries (2015-2020)
Table 53. Europe Nanoparticles Revenue (Million USD) by Countries (2015-2020)
Table 54. Asia-Pacific Nanoparticles Revenue (Million USD) by Countries (2015-2020)
Table 55. South America Nanoparticles Revenue by Countries (2015-2020)
Table 56. South America Nanoparticles Revenue Market Share by Countries (2015-2020)
Table 57. Middle East and Africa Nanoparticles Revenue (Million USD) by Countries (2015-2020)
Table 58. Middle East and Africa Nanoparticles Revenue Market Share by Countries (2015-2020)
Table 59. Global Nanoparticles Revenue (Million USD) by Type (2015-2020)
Table 60. Global Nanoparticles Revenue Share by Type (2015-2020)
Table 61. Global Nanoparticles Revenue Forecast by Type (2021-2025)
Table 62. Global Nanoparticles Revenue by Application (2015-2020)
Table 63. Global Nanoparticles Revenue Share by Application (2015-2020)
Table 64. Global Nanoparticles Revenue Forecast by Application (2021-2025)
Table 65. Global Nanoparticles Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Nanoparticles Picture
Figure 2. Global Nanoparticles Revenue Market Share by Type in 2019
Figure 3. Liposomes Picture
Figure 4. Polymer-Conjugated Drugs Picture
Figure 5. Polymeric Nanoparticles Picture
Figure 6. Dendrimers Picture
Figure 7. Inorganic Nanoparticles Picture
Figure 8. Others Picture
Figure 9. Nanoparticles Revenue Market Share by Application in 2019
Figure 10. Hospitals Picture
Figure 11. Ambulatory Surgery Centers Picture
Figure 12. Diagnostic Centers Picture
Figure 13. Global Nanoparticles Revenue (USD Million) and Growth Rate (2015-2025)
Figure 14. North America Nanoparticles Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Europe Nanoparticles Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Asia-Pacific Nanoparticles Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. South America Nanoparticles Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Middle East and Africa Nanoparticles Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Nanoparticles Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Global Nanoparticles Revenue Share by Players in 2019
Figure 21. Global Top 5 Players Nanoparticles Revenue Market Share in 2019
Figure 22. Global Top 10 Players Nanoparticles Revenue Market Share in 2019
Figure 23. Key Players Market Share Trend
Figure 24. Global Nanoparticles Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 25. Global Nanoparticles Revenue Market Share by Regions (2015-2020)
Figure 26. Global Nanoparticles Revenue Market Share by Regions in 2018
Figure 27. North America Nanoparticles Revenue and Growth Rate (2015-2020)
Figure 28. Europe Nanoparticles Revenue and Growth Rate (2015-2020)
Figure 29. Asia-Pacific Nanoparticles Revenue and Growth Rate (2015-2020)
Figure 30. South America Nanoparticles Revenue and Growth Rate (2015-2020)
Figure 31. Middle East and Africa Nanoparticles Revenue and Growth Rate (2015-2020)
Figure 32. North America Nanoparticles Revenue Market Share by Countries (2015-2020)
Figure 33. North America Nanoparticles Revenue Market Share by Countries in 2019
Figure 34. USA Nanoparticles Revenue and Growth Rate (2015-2020)
Figure 35. Canada Nanoparticles Revenue and Growth Rate (2015-2020)
Figure 36. Mexico Nanoparticles Revenue and Growth Rate (2015-2020)
Figure 37. Europe Nanoparticles Revenue Market Share by Countries (2015-2020)
Figure 38. Europe Nanoparticles Revenue Market Share by Countries in 2019
Figure 39. Germany Nanoparticles Revenue and Growth Rate (2015-2020)
Figure 40. UK Nanoparticles Revenue and Growth Rate (2015-2020)
Figure 41. France Nanoparticles Revenue and Growth Rate (2015-2020)
Figure 42. Russia Nanoparticles Revenue and Growth Rate (2015-2020)
Figure 43. Italy Nanoparticles Revenue and Growth Rate (2015-2020)
Figure 44. Asia-Pacific Nanoparticles Revenue Market Share by Countries (2015-2020)
Figure 45. Asia-Pacific Nanoparticles Revenue Market Share by Countries in 2019
Figure 46. China Nanoparticles Revenue and Growth Rate (2015-2020)
Figure 47. Japan Nanoparticles Revenue and Growth Rate (2015-2020)
Figure 48. Korea Nanoparticles Revenue and Growth Rate (2015-2020)
Figure 49. India Nanoparticles Revenue and Growth Rate (2015-2020)
Figure 50. Southeast Asia Nanoparticles Revenue and Growth Rate (2015-2020)
Figure 51. South America Nanoparticles Revenue Market Share by Countries (2015-2020)
Figure 52. South America Nanoparticles Revenue Market Share by Countries in 2019
Figure 53. Brazil Nanoparticles Revenue and Growth Rate (2015-2020)
Figure 54. Argentina Nanoparticles Revenue and Growth Rate (2015-2020)
Figure 55. Middle East and Africa Nanoparticles Revenue Market Share by Countries (2015-2020)
Figure 56. Middle East and Africa Nanoparticles Revenue Market Share by Countries in 2019
Figure 57. Saudi Arabia Nanoparticles Revenue and Growth Rate (2015-2020)
Figure 58. UAE Nanoparticles Revenue and Growth Rate (2015-2020)
Figure 59. Egypt Nanoparticles Revenue and Growth Rate (2015-2020)
Figure 60. South Africa Nanoparticles Revenue and Growth Rate (2015-2020)
Figure 61. Global Nanoparticles Revenue Share by Type (2015-2020)
Figure 62. Global Nanoparticles Revenue Share by Type in 2019
Figure 63. Global Nanoparticles Market Share Forecast by Type (2021-2025)
Figure 64. Global Liposomes Revenue Growth Rate (2015-2020)
Figure 65. Global Polymer-Conjugated Drugs Revenue Growth Rate (2015-2020)
Figure 66. Global Polymeric Nanoparticles Revenue Growth Rate (2015-2020)
Figure 67. Global Dendrimers Revenue Growth Rate (2015-2020)
Figure 68. Global Inorganic Nanoparticles Revenue Growth Rate (2015-2020)
Figure 69. Global Others Revenue Growth Rate (2015-2020)
Figure 70. Global Nanoparticles Revenue Share by Application (2015-2020)
Figure 71. Global Nanoparticles Revenue Share by Application in 2019
Figure 72. Global Nanoparticles Market Share Forecast by Application (2021-2025)
Figure 73. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 74. Global Ambulatory Surgery Centers Revenue Growth Rate (2015-2020)
Figure 75. Global Diagnostic Centers Revenue Growth Rate (2015-2020)
Figure 76. Global Nanoparticles Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 77. Global Nanoparticles Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 78. Global Nanoparticles Revenue Market Share Forecast by Regions (2021-2025)
Figure 79. North America Nanoparticles Revenue Market Forecast (2021-2025)
Figure 80. Europe Nanoparticles Revenue Market Forecast (2021-2025)
Figure 81. Asia-Pacific Nanoparticles Revenue Market Forecast (2021-2025)
Figure 82. South America Nanoparticles Revenue Market Forecast (2021-2025)
Figure 83. Middle East and Africa Nanoparticles Revenue Market Forecast (2021-2025)
Figure 84. Sales Channel: Direct Channel vs Indirect Channel
磁性ナノ粒子の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Magnetic Nanoparticles market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Magnetic Nanoparticles…- 酸化セリウムナノ粒子の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Cerium Oxide Nanoparticles market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 10.5% in the forecast period of 2020 to 2025 and will expected to reach USD 448.4 million by 2025, from USD 300.5 million in 2019. The Cerium Oxi…
- 金属ナノ粒子の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Metal Nanoparticles market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 11.8% in the forecast period of 2020 to 2025 and will expected to reach USD 18320 million by 2025, from USD 11730 million in 2019. The Metal Nanoparticl…
- ナノ粒子-金属及び金属酸化物の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Nanoparticles - Metal & Metal Oxides market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Nanopart…
- 酸化亜鉛ナノ粒子の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Zinc Oxide Nanoparticles market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Zinc Oxide Nanoparti…